BIOTECH

BIOTECH

Mentara Therapeutics Launches to Advance MTA-304 for Levodopa-Induced Dyskinesia in Parkinson’s Disease

7 October 2026 SPRIM Global Investments-backed Mentara Therapeutics has launched following its acquisition of the...

Read more

BIOTECH

Body Vision Medical Closes New Funding Round to Accelerate Global Expansion of AI-Powered Intraoperative Imaging

Body Vision Medical, a global leader in AI-powered intraoperative imaging, has closed a new round...

Read more

BIOTECH

EBT Medical and NinaMED Announce US$13.75M Financing to Advance Licensed NiNA System® for Overactive Bladder

US$13.75M financing completed to accelerate clinical pathway and global commercialisation Establishment of NinaMED Pty Ltd,...

Read more

BIOTECH

Hope for Dry AMD: Novel Gene Therapy Completes First Human Safety Trial

Paris, France – April 23, 2026 – In a significant development for the millions suffering...

Read more

BIOTECH

Dosing completed in the Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy (GA)

Paris, France, January 22, 2026 – PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing...

Read more